| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.27 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |